Bausch Health Companies (BHC) EBT (2009 - 2026)
Bausch Health Companies (BHC) reported EBT of -$1.4 billion for Q1 2026, down 2780.85% on a YoY basis from $50.5 million in Q1 2025, and down 2517.86% sequentially from $56.0 million in Q4 2025.
Bausch Health Companies (BHC) EBT (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of EBT data on file, last reported at -$1.4 billion in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 2780.85% year-over-year to -$1.4 billion; the trailing twelve-month figure through Mar 2026 stood at -$940.0 million (down 597.35% YoY), and the FY2025 full-year result was $367.0 million, up 119.76% from the prior year.
- EBT fell to -$1.4 billion in Q1 2026, from $56.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of $439.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
- A 5-year average of -$78.8 million and a median of -$21.0 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT jumped 3085.71% in 2024 and sank 2780.85% in 2026, its largest moves.
- Tracing BHC's EBT over 5 years: stood at -$357.0 million in 2022, then surged by 98.04% to -$7.0 million in 2023, then jumped by 3085.71% to $209.0 million in 2024, then slumped by 73.21% to $56.0 million in 2025, then sank by 2517.86% to -$1.4 billion in 2026.
- Business Quant data shows BHC's EBT at -$1.4 billion in Q1 2026, $56.0 million in Q4 2025, and $218.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | -1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.35 Bn |
| Dec 31, 2025 | 56.00 Mn |
| Sep 30, 2025 | 218.00 Mn |
| Jun 30, 2025 | 140.00 Mn |
| Mar 31, 2025 | -47.00 Mn |
| Dec 31, 2024 | 209.00 Mn |
| Sep 30, 2024 | -21.00 Mn |
| Jun 30, 2024 | 48.00 Mn |
| Mar 31, 2024 | -69.00 Mn |
| Dec 31, 2023 | -7.00 Mn |
| Sep 30, 2023 | -326.00 Mn |
| Jun 30, 2023 | 79.00 Mn |
| Mar 31, 2023 | -136.00 Mn |
| Dec 31, 2022 | -357.00 Mn |
| Sep 30, 2022 | 439.00 Mn |
| Jun 30, 2022 | -129.00 Mn |
| Mar 31, 2022 | -82.00 Mn |
| Dec 31, 2021 | 21.00 Mn |
| Sep 30, 2021 | 216.00 Mn |
| Jun 30, 2021 | -670.00 Mn |